A detailed history of Price T Rowe Associates Inc transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 134,700 shares of KPTI stock, worth $105,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares
134,700
Previous 97,100 38.72%
Holding current value
$105,066
Previous $84,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.7 - $1.06 $26,320 - $39,856
37,600 Added 38.72%
134,700 $112,000
Q2 2024

Aug 14, 2024

BUY
$0.87 - $1.58 $1,747 - $3,174
2,009 Added 2.11%
97,100 $84,000
Q1 2024

May 15, 2024

BUY
$0.72 - $1.66 $5,744 - $13,243
7,978 Added 9.16%
95,091 $144,000
Q3 2023

Nov 14, 2023

BUY
$1.14 - $1.81 $21,665 - $34,399
19,005 Added 27.9%
87,113 $117,000
Q2 2023

Aug 14, 2023

BUY
$1.79 - $4.59 $13,679 - $35,076
7,642 Added 12.64%
68,108 $122,000
Q1 2023

May 15, 2023

BUY
$2.84 - $3.92 $7,131 - $9,843
2,511 Added 4.33%
60,466 $236,000
Q4 2022

Feb 14, 2023

BUY
$2.48 - $5.93 $13,449 - $32,158
5,423 Added 10.32%
57,955 $197,000
Q3 2022

Nov 14, 2022

BUY
$4.08 - $5.82 $60,636 - $86,496
14,862 Added 39.45%
52,532 $287,000
Q2 2022

Aug 15, 2022

BUY
$4.15 - $8.37 $47,193 - $95,183
11,372 Added 43.24%
37,670 $170,000
Q1 2022

May 16, 2022

BUY
$5.91 - $14.38 $34,786 - $84,640
5,886 Added 28.84%
26,298 $194,000
Q4 2021

Feb 14, 2022

SELL
$5.21 - $8.61 $127,645 - $210,945
-24,500 Reduced 54.55%
20,412 $131,000
Q3 2021

Nov 15, 2021

SELL
$4.45 - $10.63 $1.58 Million - $3.77 Million
-354,187 Reduced 88.75%
44,912 $261,000
Q2 2021

Aug 16, 2021

SELL
$8.11 - $11.11 $761,172 - $1.04 Million
-93,856 Reduced 19.04%
399,099 $4.12 Million
Q1 2021

May 17, 2021

SELL
$9.85 - $17.69 $9.49 Million - $17.1 Million
-963,946 Reduced 66.16%
492,955 $5.19 Million
Q4 2020

Feb 16, 2021

BUY
$14.15 - $17.19 $20.6 Million - $25 Million
1,456,901 New
1,456,901 $22.6 Million

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $62.2M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.